Related Experiment Video
Updated: Apr 13, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.4K
BAG3: a new player in the heart failure paradigm
Tijana Knezevic1, Valerie D Myers, Jennifer Gordon
1Department of Neuroscience, Temple University School of Medicine, 3500 N. Broad Street, Suite 1150, Philadelphia, PA, 19140, USA.
Heart Failure Reviews
|May 1, 2015
Summary
BAG3 protein is crucial for heart muscle health and preventing heart failure. Reduced BAG3 levels are linked to heart failure, highlighting its therapeutic potential for dilated cardiomyopathy.
Area of Science:
- Molecular Biology
- Cardiovascular Science
- Cellular Biology
Background:
- BAG3 is a cellular protein found in muscle and nerve tissues.
- It functions as a co-chaperone, aids in protein quality control, inhibits apoptosis, and maintains muscle structure.
- Mutations in BAG3 are linked to familial dilated cardiomyopathy.
Purpose of the Study:
- To understand the cellular biology and molecular regulation of BAG3 expression.
- To explore BAG3's role in myocyte homeostasis and heart failure development.
- To identify potential therapeutic targets for dilated cardiomyopathy.
Main Methods:
- The abstract does not specify methods, but implies analysis of BAG3 levels and mutations in human and animal models.
- Studies likely involved genetic analysis, protein level quantification, and potentially cellular assays.
Main Results:
- BAG3 mutations are associated with familial dilated cardiomyopathy.
- Decreased BAG3 levels are observed in end-stage failing human hearts.
- Reduced BAG3 is also found in animal models of heart failure.
Conclusions:
- BAG3 plays a critical role in maintaining cardiac myocyte health.
- Dysregulation of BAG3 is implicated in the pathogenesis of heart failure.
- Understanding BAG3 regulation is key for developing new therapies for dilated cardiomyopathy.
More Related Videos
Related Concept Videos
01:26Heart Failure III: Clinical Manifestations
934
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
934
01:30Heart Failure IV: Classification and Diagnostic Evaluation
619
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
619
01:27Heart Failure I: Introduction
1.3K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
01:30Heart Failure V: Medical Management
567
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
567
01:29Heart Failure II: Pathophysiology
1.5K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
01:21Rheumatic Heart Disease III: Medical Management
523
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
523